Anti-EJ Antibody-positive Anti-synthetase Syndrome Associated with Retroperitoneal Sarcoma

被引:3
作者
Fukui, Saeko [1 ]
Kobayashi, Kazuma [1 ]
Fujita, Yuya [2 ]
Fukui, Shoichi [2 ]
Iwamoto, Naoki [2 ]
Adachi, Tomohiko [1 ]
Hidaka, Masaaki [1 ]
Takatsuki, Mitsuhisa [1 ]
Abe, Kuniko [3 ]
Kuwana, Masataka [4 ]
Kawakami, Atsushi [2 ]
Eguchi, Susumu [1 ]
机构
[1] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki, Japan
[2] Nagasaki Univ Hosp, Dept Immunol & Rheumatol, Nagasaki, Japan
[3] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan
[4] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
anti-synthetase syndrome (ASS); anti-EJ antibody; sarcoma; dermatomyositis (DM); paraneoplastic syndrome; IDIOPATHIC INFLAMMATORY MYOPATHIES; DERMATOMYOSITIS; POLYMYOSITIS; AUTOANTIBODIES; MYOSITIS; CRITERIA; DISEASE;
D O I
10.2169/internalmedicine.3923-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 74-year-old man with interstitial lung disease (ILD) underwent surgical excision of a growing retroperitoneal tumor and was diagnosed with spindle cell sarcoma. Just after the surgery, skin eruption and muscle weakness emerged. Based on his symptoms and examination findings, we diagnosed him with anti-synthetase syndrome (ASS) with positive anti-glycyl-transfer ribonucleic acid synthetase antibody (anti-EJ) as paraneoplastic syndrome. Immunosuppressive treatments kept his progressing ILD stable for 21 months, although an expanding lung metastatic lesion from primary sarcoma was detected. Measurements of myositis-specific antibodies may enable the prediction of the efficacy of immunosuppressive treatments for paraneoplastic syndrome, even if the primary disease becomes progressive.
引用
收藏
页码:2071 / 2076
页数:6
相关论文
共 22 条
  • [1] Bendewald MJ, 2010, ARCH DERMATOL, V146, P26, DOI 10.1001/archdermatol.2009.328
  • [2] Pulmonary metastases from soft tissue sarcoma - Analysis of patterns of disease and postmetastasis survival
    Billingsley, KG
    Burt, ME
    Jara, E
    Ginsberg, RJ
    Woodruff, JM
    Leung, DHY
    Brennan, MF
    [J]. ANNALS OF SURGERY, 1999, 229 (05) : 602 - 612
  • [3] POLYMYOSITIS AND DERMATOMYOSITIS .2.
    BOHAN, A
    PETER, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) : 403 - 407
  • [4] POLYMYOSITIS AND DERMATOMYOSITIS .1.
    BOHAN, A
    PETER, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) : 344 - 347
  • [5] The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
    Chinoy, Hector
    Fertig, Noreen
    Oddis, Chester V.
    Ollier, William E. R.
    Cooper, Robert G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) : 1345 - 1349
  • [6] AN OVERVIEW OF POLYMYOSITIS AND DERMATOMYOSITIS
    Findlay, Andrew R.
    Goyal, Namita A.
    Mozaffar, Tahseen
    [J]. MUSCLE & NERVE, 2015, 51 (05) : 638 - 656
  • [7] Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447
  • [8] Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Matsushita, Takashi
    Kaji, Kenzo
    Komura, Kazuhiro
    Hasegawa, Minoru
    Kodera, Masanari
    Muroi, Eiji
    Fujikawa, Keita
    Seishima, Mariko
    Yamada, Hidehiro
    Yamada, Ryo
    Sato, Shinichi
    Takehara, Kazuhiko
    Kuwana, Masataka
    [J]. PLOS ONE, 2013, 8 (04):
  • [9] Antisynthetase Syndrome
    Katzap, Elena
    Barilla-LaBarca, Maria-Louise
    Marder, Galina
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (03) : 175 - 181
  • [10] The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome
    Lega, Jean-Christophe
    Fabien, Nicole
    Reynaud, Quitterie
    Durieu, Isabelle
    Durupt, Stephane
    Dutertre, Marine
    Cordier, Jean-Francois
    Cottin, Vincent
    [J]. AUTOIMMUNITY REVIEWS, 2014, 13 (09) : 883 - 891